Virus purification and formulation process

Disclosed herein is provided a virus purification and formulation process for purifying a flavivirus represented by one of a a Yellow Fever Virus, Japanese Encephalitis virus, Dengue virus, and West Nile virus . The highly purified flavivirus virus product is characterized as having a low level of s...

Full description

Saved in:
Bibliographic Details
Main Authors Vicalvi, John J., Jr, Hayman, Edward G, Makowiecki, Joseph
Format Patent
LanguageEnglish
French
German
Published 22.11.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed herein is provided a virus purification and formulation process for purifying a flavivirus represented by one of a a Yellow Fever Virus, Japanese Encephalitis virus, Dengue virus, and West Nile virus . The highly purified flavivirus virus product is characterized as having a low level of sucrose without significant virus loss such as that which is typically encountered by prior art virus purification processes. The disclosed process captures and purifies the virus, separating it from the host cell proteins and DNA, and leaving the host cell proteins and DNA behind. The process also can be used to inactivate and/or concentrate the virus sufficiently for use in formulations.
Bibliography:Application Number: EP20130181160